MedElevator Войти в исследования
← Поиск публикаций

DOI 10.4269/ajtmh.21-0978

Медицинская библиотека · The American journal of tropical medicine and hygiene · 2022

Preliminary Study for New Markers of Early Tubuloglomerular Injury and Renal Inflammation in Patients with Visceral Leishmaniasis Receiving Liposomal Amphotericin B Treatment.

Bezerra Gabriela Freire, Meneses Gdayllon Cavalcante, Jacinto Vittória Nobre, Lima Danya Bandeira, Magalhães Emanuel Paula, Lima Lana Andrade Lucena, Rocha Thaiany Pereira da, de Azevedo Isabella Evelyn Prado, da Silva Geraldo Bezerra, Daher Elizabeth De Francesco, Martins Alice Maria Costa

СтатьяПеревод пока не подготовлен

Аннотация

Visceral leishmaniasis is treated with liposomal amphotericin B (L-AMB), which is associated with nephrotoxicity. Thus, we aimed to investigate nephrotoxicity through novel renal biomarkers in patients with visceral leishmaniasis during L-AMB use. Ours was a prospective study with 17 patients with visceral leishmaniasis treated with L-AMB during their hospital stay. Laboratory tests, renal parameters, urinary biomarkers (urinary kidney injury molecule 1, urinary monocyte chemoattractant protein 1 [uMCP-1], sodium-potassium-2 chloride cotransporter [NKCC2], sodium-hydrogen exchanger 3) [NHE3], aquaporin 2 [AQP2], tumor susceptibility gene 101 [TSH 101], and serum inflammatory biomarkers (MCP-1, interferon-γ, and IL-6) were evaluated in two periods: before and during L-AMB use. Glomerular filtration rate, creatinine, proteinuria, and albuminuria were similar before and during L-AMB use. IL-6 levels, AQT2, and NHE3 expression decreased, whereas uMCP-1 and urinary kidney injury molecule 1 levels increased during L-AMB treatment. In patients who developed acute kidney injury, uMCP-1 showed higher levels. L-AMB aggravated tubuloglomerular lesions, inflammation, and renal tubular disorders. Thus, patients treated with L-AMB need to be monitored for inflammatory and electrolyte disturbances to prevent acute kidney injury, longer length of hospital stay, higher public costs, and mortality.

Для цитирования: Bezerra Gabriela Freire, Meneses Gdayllon Cavalcante, Jacinto Vittória Nobre, Lima Danya Bandeira, Magalhães Emanuel Paula, Lima Lana Andrade Lucena, Rocha Thaiany Pereira da, de Azevedo Isabella Evelyn Prado, da Silva Geraldo Bezerra, Daher Elizabeth De Francesco, Martins Alice Maria Costa. Preliminary Study for New Markers of Early Tubuloglomerular Injury and Renal Inflammation in Patients with Visceral Leishmaniasis Receiving Liposomal Amphotericin B Treatment.. The American journal of tropical medicine and hygiene. 2022. DOI: 10.4269/ajtmh.21-0978.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.